Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Index
-
Market Cap
40.05B
Enterprise Value
49.99B
Income
2.18B
Sales
14.97B
Book/sh
4.96
Cash/sh
0.25
Employees
-
IPO
Jul 18, 2022
P/E
18.76
Forward P/E
15.36
PEG
1.96
P/S
2.68
P/B
1.84
P/C
36.53
P/FCF
14.56
EV/EBITDA
12.62
EV/Sales
3.34
Quick Ratio
0.52
Current Ratio
0.69
Debt/Eq
0.50
LT Debt/Eq
0.38
Option/Short
Yes / Yes
EPS (ttm)
0.49
EPS next Y
0.59
EPS next Q
0.15
EPS this Y
9.64%
EPS next Y
6.44%
EPS next 5Y
7.82%
EPS past 3/5Y
20.04% 9.00%
Sales past 3/5Y
2.82% 2.76%
EPS Y/Y TTM
12.37%
Sales Y/Y TTM
4.99%
EPS Q/Q
24561.95%
Sales Q/Q
15.22%
Insider Own
0.00%
Insider Trans
-
Inst Own
16.14%
Inst Trans
-1.27%
ROA
5.02%
ROE
9.99%
ROIC
7.24%
Gross Margin
65.46%
Oper. Margin
23.31%
Profit Margin
14.55%
SMA20
-0.56%
SMA50
-2.07%
SMA200
-5.63%
Trades
Shs Outstand
4.39B
Shs Float
4.39B
52W High
11.28 -19.10%
52W Low
8.38 8.89%
Volatility
1.29% 1.88%
ATR (14)
0.20
RSI (14)
46.21
Beta
0.10
Rel Volume
0.87
Avg Volume
18.86M
Volume
9,298,668
Perf Week
-0.49%
Perf Month
-12.01%
Perf Quarter
-10.19%
Perf Half Y
-1.78%
Perf YTD
-9.74%
Perf Year
-4.95%
Perf 3Y
10.61%
Perf 5Y
-
Perf 10Y
-
Prev Close
9.05
Price
9.12
Change %
0.83%
Consensus
Buy
Avg. Price Target
$10.21
Implied Upside
+11.9%
Analysts11incl. previous ratings
Rating Distribution6 Buy · 5 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Nov 04, 2026Downgrade
JEF logoJJefferies
Buy → Hold
Oct 30, 2026Upgrade
DB logoDDeutsche Bank
Sell → Hold
Jan 23, 2026Upgrade
BCS logoBBarclays
Equal Weight → Overweight
Sep 16, 2025Downgrade
BCS logoBBarclays
Overweight → Equal Weight
Sep 10, 2025Upgrade
GS logoGGoldman
Neutral → Buy
May 27, 2025Upgrade
BBNP Paribas Exane
Neutral → Outperform$13.40+46.8%
May 09, 2025Upgrade
MS logoMMorgan Stanley
Equal-Weight → Overweight$11.25+23.3%
Mar 05, 2025Downgrade
HSBC logoHHSBC Securities
Buy → Hold
Jan 10, 2025Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight
Jan 08, 2025Downgrade
BBernstein
Outperform → Mkt Perform
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
CEO & Executive DirectorMr. Brian James McNamara
CFO & DirectorMs. Dawn Amanda Allen
Chief Digital & Technology OfficerMs. Claire Dickson
Head of Investor RelationsMs. Joanne Russell
General CounselMr. Adrian Charles Morris